about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Armed with pub­lished an­i­mal da­ta, gene-edit­ing pi­o­neer In­tel­lia maps the road to an IND

8 years ago
Discovery

Ex­elix­is/Dai­ichi Sankyo ask Japan­ese reg­u­la­tors for green light on hy­per­ten­sion drug; Bris­tol-My­ers Squibb li­cens­es ...

8 years ago
News Briefing

Glob­al syn­di­cate backs Prokar­i­um's $10M round; Bavar­i­an Nordic to test can­cer vac­cine with Imfinzi; AI start­up buys ...

8 years ago
News Briefing

Where does the sci­ence come from? The top 20 NIH-fund­ed in­sti­tu­tions in 2017

8 years ago
Discovery
In Focus

Seek­ing greater gen­der di­ver­si­ty, Al­ny­lam pro­motes four fe­male lead­ers; Paul Hast­ings starts post-On­coMed ca­reer as ...

8 years ago
Peer Review

Hit by an ex­pect­ed EMA re­jec­tion, Puma plans to ap­peal neg­a­tive opin­ion on ner­a­tinib

8 years ago
Pharma

Fast ex-Flexus team takes Ar­cus to a quick $100M IPO to ad­vance I/O pipeline

8 years ago
Financing

On a jour­ney to find and fu­el new biotech ven­tures, Ar­ix adds France's Ipsen to its net­work of part­ners

8 years ago
R&D
Pharma

As­traZeneca hauls kid­ney dis­ease drug in­to the clin­ic af­ter hand­ing Io­n­is $30M in cash, $300M in mile­stones

8 years ago
R&D
Pharma

Roivant Sci­ences in ex­clu­sive joint ven­ture talks with Ar­bu­tus; DBV gets green light to sub­mit peanut al­ler­gy patch

8 years ago
News Briefing

Ex-Ax­o­vant COO Mar­i­on Mc­Court lands at Re­gen­eron; GT Bio­phar­ma el­e­vates Shawn Cross to CEO in ex­ec reshuf­fle

8 years ago
Peer Review

Ar­a­digm los­es CEO, CMO and CFO fol­low­ing reg­u­la­to­ry dis­as­ter; Omeros shares go up on pos­i­tive re­sults for blood clot ...

8 years ago
News Briefing

Pfiz­er, Mer­ck KGaA say their PD-L1 Baven­cio al­so flunked PhI­II in the all-im­por­tant lung can­cer field

8 years ago
R&D

Cure­Vac to de­vel­op mR­NA-based flu, malar­ia vac­cines with new Gates Foun­da­tion grants

8 years ago
R&D

Switzer­land's Fer­ring Phar­ma to build $32M dis­cov­ery, de­vel­op­ment and man­u­fac­tur­ing cen­ter at HQ

8 years ago
Pharma

No­var­tis, Mo­men­ta grab a de­layed FDA OK for block­buster Co­pax­one knock­off

8 years ago
Pharma

Roche posts pos­i­tive PhII re­sults for bis­pe­cif­ic an­ti­body eye drug, join­ing No­var­tis in ri­val­ry with Eylea

8 years ago
R&D

CEO Eliot Forster leaves Im­muno­core as the UK biotech uni­corn hunts cash

8 years ago
People
Peer Review

CSO Bill Lund­berg tran­si­tions to ad­vi­sor role at CRISPR Ther­a­peu­tics; Prothena los­es CMO Sarah Noon­berg; Sanofi vet ...

8 years ago
Peer Review

A week of UK deals ex­em­pli­fies Chi­na’s grow­ing role in glob­al biotech in­vest­ment

8 years ago
China

Sage seeks $575M in pub­lic of­fer­ing; Pfiz­er inks dis­cov­ery pact with Chi­nese firm

8 years ago
News Briefing

Ge­nomics meets blockchain: Har­vard team fea­tur­ing George Church launch­es peer-to-peer genome se­quenc­ing start­up

8 years ago
Startups

North of a bil­lion biotech VC dol­lars to come from C-Bridge, Roth­schild as glob­al bio­phar­ma cap­i­tal flows

8 years ago
Financing

Nes­san Berming­ham re­turns to VC life; Sanofi's gener­ics unit gets two in­dus­try bid­ders in EMS and Tor­rent Phar­ma

8 years ago
News Briefing
First page Previous page 120121122123124125126 Next page Last page
A service from the Financial Times